Total RNA was extracted from tissue samples using
TRIzol (Invitrogen) according to the manufacturer’s protocol. Samples were treated with DNase using the
RNase-free DNase Set (Qiagen) during the total RNA isolation. First strand complementary DNA (cDNA) was synthesized using the
cDNA Synthesis kit (Thermo Fisher Scientific) according to the manufacturer’s instructions.
ABI prism 7900-HT sequence detection system (96-well, Applied Biosystems) was used to perform quantitative real-time PCR (RT-PCR) analysis. For RT-PCR, the following primers were used:
GAPDH: 5′- GACTCATGACCACAGTCCATGC-3′ (forward), 5′- AGAGGCAGGGATGATGTTCTG-3′ (reverse).
H1FX-AS1: 5′- GATGGGGAAGGGATTCGCTC-3′ (forward), 5′- TCTCCTTTGCTGTGTTCCCG-3′ (reverse).
AL441992.1: 5′- AAGAAGCTCTCGTGTGGCTC-3′ (forward), 5′- TGGCTTTGAAGCGAGGATGA-3′ (reverse).
USP30-AS1: 5′- AGCAATAGCTGACGGACCAC-3′ (forward), 5′- TGAAAACCAAGCAGCCCCA-3′ (reverse).
AP001527.2: 5′- ATTGGGAATGACTCATCTGTTTG-3′ (forward), 5′- AGCAGTAGACTCCCAGGAAAG-3′ (reverse).
AL031123.2: 5′- ACACACGTGGTCTGTAGCG-3′ (forward), 5′- GGGCCTTGCTTTCCCCATAA-3′ (reverse).
All samples were processed in triplicate. The relative gene expression was determined using the 2
−ΔΔCT method.
Chen P., Gao Y., Ouyang S., Wei L., Zhou M., You H, & Wang Y. (2020). A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer. Frontiers in Pharmacology, 11, 585255.